Key result
Women show ~25% lower risk of incident HF than men despite shared biomarker-driven prediction.
Why the study?
It was unclear whether cardiovascular disease risk factors and biomarkers associate differentially with heart failure risk in men and women.
Do cardiovascular risk factors and biomarkers associate differentially with incident heart failure risk in men and women?
Cohort (n=22,756)
Yes
Do cardiovascular risk factors and biomarkers associate differentially with incident heart failure risk in men and women?
Answers are grounded in this paper and cite their sources.
Cardiovascular risk factors are strongly and similarly associated with incident heart failure in both men and women, with biomarkers adding only limited predictive value to clinical models.
BACKGROUND: Whether cardiovascular (CV) disease risk factors and biomarkers associate differentially with heart failure (HF) risk in men and women is unclear. OBJECTIVES: The purpose of this study was to evaluate sex-specific associations of CV risk factors and biomarkers with incident HF. METHODS: The analysis was performed using data from 4 community-based cohorts with 12.5 years of follow-up. Participants (recruited between 1989 and 2002) were free of HF at baseline. Biomarker measurements included natriuretic peptides, cardiac troponins, plasminogen activator inhibitor-1, D-dimer, fibrinogen, C-reactive protein, sST2, galectin-3, cystatin-C, and urinary albumin-to-creatinine ratio. RESULTS: Among 22,756 participants (mean age 60 ± 13 years, 53% women), HF occurred in 2,095 participants (47% women). Age, smoking, type 2 diabetes mellitus, hypertension, body mass index, atrial fibrillation, myocardial infarction, left ventricular hypertrophy, and left bundle branch block were strongly associated with HF in both sexes (p < 0.001), and the combined clinical model had good discrimination in men (C-statistic = 0.80) and in women (C-statistic = 0.83). The majority of biomarkers were strongly and similarly associated with HF in both sexes. The clinical model improved modestly after adding natriuretic peptides in men (ΔC-statistic = 0.006; likelihood ratio chi-square = 146; p < 0.001), and after adding cardiac troponins in women (ΔC-statistic = 0.003; likelihood ratio chi-square = 73; p < 0.001). CONCLUSIONS: CV risk factors are strongly and similarly associated with incident HF in both sexes, highlighting the similar importance of risk factor control in reducing HF risk in the community. There are subtle sex-related differences in the predictive value of individual biomarkers, but the overall improvement in HF risk estimation when included in a clinical HF risk prediction model is limited in both sexes.
No takes yet. Share an insight, caveat, or question.
Suthahar et al. (2020) conducted a cohort in Incident Heart Failure (n=22,756). Female sex, cardiovascular risk factors, and circulating biomarkers vs. Male sex was evaluated on Incident heart failure (HR 0.75, 95% CI 0.68-0.82, p=<0.001). Cardiovascular risk factors and biomarkers associated strongly with incident HF in both sexes, with lower overall HF risk in women than men.
Synapse has enriched 10 related papers. Consider them for comparative context: